FOLFOX + ziv-aflibercept adding anti-angiogenic agent to chemotherapy in advanced gastric adenocarcinoma Annual Meeting GI 2016 - 101967

Spotlight
Video

FOLFOX + ziv-aflibercept adding anti-angiogenic agent to chemotherapy in advanced gastric adenocarcinoma Annual Meeting GI 2016

Loading........
Description: Daniel Catenacci, MD of The University of Chicago Medicine discusses FOLFOX + ziv-aflibercept adding anti-angiogenic agent to chemotherapy in advanced gastric adenocarcinoma at ASCO GI 2016
Shared By : Gastrointestinal-Cancer-Meeting
Posted on : 01/26/16
Added : 3 years ago